Acadian Asset Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Sell
22,402
-43,572
-66% -$973K ﹤0.01% 1568
2026
Q1
$1.73M Buy
65,974
+10,763
+19% +$1.35M ﹤0.01% 1001
2025
Q4
$13.7M Sell
55,211
-7,451
-12% -$1.7M 0.02% 416
2025
Q3
$13.2M Sell
62,662
-26,663
-30% -$4.7M 0.02% 414
2025
Q2
$8.79M Buy
89,325
+9,849
+12% +$859K 0.02% 459
2025
Q1
$6.99M Buy
79,476
+15,666
+25% +$1.45M 0.02% 402
2024
Q4
$4.62M Buy
63,810
+14,457
+29% +$991K 0.01% 543
2024
Q3
$3.89M Buy
49,353
+4,443
+10% +$342K 0.01% 564
2024
Q2
$3.23M Buy
44,910
+10,705
+31% +$641K 0.01% 625
2024
Q1
$3.23M Buy
34,205
+11,641
+52% +$1.03M 0.01% 562
2023
Q4
$1.64M Buy
22,564
+3,381
+18% +$200K 0.01% 725
2023
Q3
$1.28M Sell
19,183
-19,151
-50% -$1.77M 0.01% 804
2023
Q2
$3.68M Buy
38,334
+10,667
+39% +$1.06M 0.02% 535
2023
Q1
$2.79M Buy
27,667
+9,495
+52% +$1.45M 0.01% 622
2022
Q4
$3.15M Buy
+18,172
New +$12M 0.02% 559

Other funds holding GOSS

Acadian Asset Management's GOSS Position: Q2 2026 in Review

Acadian Asset Management reduced its Gossamer Bio (GOSS) stake by 66% in Q2 2026, selling an estimated $973K and leaving 22,402 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Acadian Asset Management first reported a position in GOSS in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.7M in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Acadian Asset Management held 22,402 shares of Gossamer Bio worth $293K as of Q2 2026.
  • Acadian Asset Management sold 43,572 Gossamer Bio shares in Q2 2026, an estimated $973K.
  • Gossamer Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1568 holding.
  • Acadian Asset Management first reported a position in Gossamer Bio in Q4 2022 and has held it in 15 quarters since.
  • Acadian Asset Management's Gossamer Bio position peaked at $13.7M in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.